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Receptor activation and 2 distinct COOH-terminal motifs control G-CSF receptor
distribution and internalization kinetics
Lambertus H. J. Aarts, Onno Roovers, Alister C. Ward, and Ivo P. Touw
We have studied the intracellular distribu-
tion and internalization kinetics of the
granulocyte colony-stimulating factor re-
ceptor (G-CSF-R) in living cells using
fusion constructs of wild-type or mutant
G-CSF-R and enhanced green fluores-
cent protein (EGFP). Under steady-state
conditions the G-CSF-R localized pre-
dominantly to the Golgi apparatus, late
endosomes, and lysosomes, with only
low expression on the plasma membrane,
resulting from spontaneous internaliza-
tion. Internalization of the G-CSF-R was
significantly accelerated by addition of
G-CSF. This ligand-induced switch from
slow to rapid internalization required the
presence of G-CSF-R residue Trp650, pre-
viously shown to be essential for its sig-
naling ability. Both spontaneous and li-
gand-induced internalization depended on
2 distinct amino acid stretches in the
G-CSF-R COOH-terminus: 749-755, con-
taining a dileucine internalization motif,
and 756-769. Mutation of Ser749 at posi-
tion 4 of the dileucine motif to Ala
significantly reduced the rate of ligand-
induced internalization. In contrast, muta-
tion of Ser749 did not affect spontaneous
G-CSF-R internalization, suggesting the
involvement of a serine-threonine kinase
specifically in ligand-accelerated internal-
ization of the G-CSF-R. COOH-terminal
truncation mutants of G-CSF-R, found in
severe congenital neutropenia, lack the
internalization motifs and were com-
pletely defective in both spontaneous and
ligand-induced internalization. As a re-
sult, these mutants showed constitu-
tively high cell-surface expression.
(Blood. 2004;103:571-579)
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Introduction
Granulocyte colony-stimulating factor (G-CSF) controls neutrophil
production by stimulating the proliferation, differentiation, and
survival of myeloid progenitor cells.1,2 Its effects are mediated
through activation of the G-CSF receptor (G-CSF-R), a single
transmembrane protein of the hematopoietin receptor superfamily
that forms homo-oligomeric complexes upon ligand binding.3,4
Like all members of this receptor superfamily, the G-CSF-R lacks
intrinsic tyrosine kinase activity but activates cytoplasmic tyrosine
kinases of the Janus kinase (Jak) and Src family.5-10 Additional
proteins that are activated by the G-CSF-R include various
members of the signal transducer and activator of transcription
(STAT) families of proteins,6,7,11-13 phosphatidylinositol 3 kinase
and its downstream substrate Akt,14-17 and components of the
p21ras/Raf/mitogen-activated protein kinase (MAPK) pathway.18-21
We have previously identified mutations in the gene encoding the
G-CSF-R in about 20% to 25% of cases of severe congenital
neutropenia (SCN). These mutations introduce premature stop
codons that lead to truncation of the C-terminal 82-98 amino acids, a
region that has been associated with leukemic progression of SCN.22-24
Upon expression of such truncated receptors in myeloid 32D cells,
proliferative signaling was elevated and maturation signaling abro-
gated.23 This hyperproliferative response, also observed in knock-in
mice with an equivalent mutation,25,26 was accompanied by sustained
activation of STAT proteins and a prolonged cell-surface expression of
mutant receptors.27-29
In view of the potential importance of receptor distribution for
G-CSF signal transduction, we set out to identify sequence
determinants in the cytoplasmic domain that control this process.
Previously, we have shown that a conserved dileucine motif
(Leu753Leu754) is important for internalization of the G-CSF-R.27
Substitution of these leucines for alanines resulted in delayed
internalization and prolonged receptor activation. However, this
dileucine mutant was not as severely affected in receptor internal-
ization as the SCN-derived truncated receptor ([d715]G-CSF-R),
implying that (an) additional motif(s) determining receptor internal-
ization reside(s) within the C-terminus of the receptor. Moreover,
these studies did not establish whether the receptor truncations
mainly affected constitutive or ligand-dependent G-CSF-R internal-
ization. This question has become of particular relevance in view of
recent studies showing that internalization of other members of the
hematopoietin receptor superfamily (ie, the interleukin-6 [IL-6]
signal transducing component gp130 and receptors for erythropoi-
etin and growth hormone) do not require receptor activation for
internalization.30-32
Here, we first analyzed the distribution of a panel of mutant
enhanced green fluorescent protein (EGFP)–tagged G-CSF recep-
tors in living cells by confocal laser scanning microscopy (CLSM).
We show that the cell-surface expression level of the truncated
[d715]G-CSF-R is dramatically increased compared with the
wild-type (wt) G-CSF-R resulting from reduced spontaneous
internalization. Subsequently, we demonstrate by flow cytometry
and CLSM that ligand binding greatly increases the rate of
G-CSF-R internalization. Both spontaneous and ligand-induced
internalization are guided by 2 adjacent internalization motifs
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(amino acids 749-755 and 756-769). Finally, fast, ligand-induced
receptor internalization was shown to depend on the integrity of a
crucial tryptophan residue (Trp650) involved in Jak activation and
on the phosphorylation status of a serine residue within a serine-
type dileucine internalization motif (amino acids 749-755). To-
gether, our data provide a detailed assessment of sequence determi-
nants that control G-CSF-R distribution and internalization.
Materials and methods
Antibodies
Biotinylated mouse antihuman G-CSF-R monoclonal antibody (LMM741),
recognizing an N-terminal, extracellular epitope of the G-CSF-R, was
purchased from BD PharMingen (San Diego, CA). Phycoerythrine-
conjugated streptavidin (SA-PE) was from Caltag Laboratories (Burlin-
game, CA). Monoclonal antibodies against GM130, BiP, and EEA1 were
obtained from BD Transduction Laboratories (San Diego, CA). Polyclonal
antibodies against Rab7 and Lamp-1 (clone 1D4B) were obtained from
Santa Cruz Biotechnology (Santa Cruz, CA) and Research Diagnostics
(Flanders, NJ), respectively. Antibodies against ERGIC-53 and Sec31 were
kindly provided by Dr H. P. Hauri and Dr B. L. Tang, respectively.
Expression constructs
To create mutant G-CSF-R constructs, we used the pLNCX retroviral
expression vector containing full-length human wild-type (wt) G-CSF-R as
a template.27 This construct contains a silent mutation introducing a unique
HpaI restriction site at amino acid 616 and a unique BglII restriction site 3
of the stop codon. Truncated G-CSF-R constructs were created by the
introduction of a stop codon at the desired position by polymerase chain
reaction (PCR), using the Stratagene QuickChange site-directed mutagen-
esis kit (Stratagene, La Jolla, CA). Other single amino acid changes and
multiple amino acid deletions were created using oligonucleotides contain-
ing the desired mutation or containing nucleotide stretches flanking the
desired deletions. The pLNCX expression vectors containing the human
C-terminal deletion mutant d715, the dileucine substitution mutant
L753754A, W650R, and mA have been described previously.11,18,27 The
authenticity of all constructs was verified by restriction enzyme analysis
and DNA sequencing, followed by recloning in the pBabe expression
vector. The [d715-STQPLL]G-CSF-R construct was created by PCR using
a 5 oligonucleotide spanning a region in the cDNA corresponding to amino
acids 590-595 (GRFR7) and a 3 oligonucleotide containing a segment
spanning the amino acids immediately upstream of amino acid 715 of the
G-CSF-R, a segment coding for STQPLL and a BglII restriction site.
Following PCR, HpaI and BglII fragments were ligated in pBabe contain-
ing wt G-CSF-R from which the wt HpaI/BglII fragment had been removed.
A schematic representation of the intracellular domains of these constructs
is given in Figure 1.
To create the wt G-CSF-R/EGFP fusion construct, a first PCR was
performed using GRFR7 as the forward primer and a 3 chimeric
oligonucleotide (GRWT/EGFP), spanning a 3 segment of the G-CSF-R
and a 5 segment of EGFP, as the reverse primer, to amplify a C-terminal
G-CSF-R fragment. Secondly, to amplify the EGFP cDNA, a 5 chimeric
oligonucleotide (EGFP/GRWT) was used spanning the 5 segment of EGFP
and the 3 segment of wt G-CSF-R and a 3 oligonucleotide spanning the 3
segment of EGFP and containing a BglII restriction site (EGFP/BglII),
using pEGFP-C1 (Clontech Laboratories, Palo Alto, CA) as a template.
Finally, products of these PCR products were isolated, mixed 1:1, and used
as templates for a PCR using GRFR7 and EGFP/BglII as primers. The
resulting fragments were digested with HpaI and BglII and ligated in pBabe
containing wt G-CSF-R that had also been digested with HpaI and BglII.
The various truncated G-CSF-R/EGFP fusions were made in a similar way
using GRFR7 and EGFP/BglII together with the appropriate chimeric
primers spanning the 5 segment of EGFP and the segment 5 to the desired
G-CSF-R truncation. EGFP fusions of deletion constructs or mutant
G-CSF-R constructs were created as the wt G-CSF-R/EGFP fusion but now
using pBabe constructs with the various mutant receptor cDNAs.
Cell culture, transfection, and retroviral transduction
32D.cl8.6, a subline of the IL-3–dependent murine myeloid 32Dcl3 cell line
that lacks endogenous G-CSF-R expression,33 was maintained in RPMI
1640 medium supplemented with 10% fetal calf serum (FCS), 100 IU/mL
penicillin, 100 g/mL streptomycin, and murine IL-3 (10 ng/mL) at 37°C
and 5% CO2. To obtain retrovirus, Phoenix E packaging cells were seeded
at 4  105 cells per 5-cm dish and transfected (the next day) by the
calcium-phosphate precipitation method. The following day, medium was
replenished. Virus-containing supernatant was harvested 48 hours after
transfection, passed through a 0.45-m filter, and either frozen in80°C or
directly used to transduce 32D.cl8.6 cells. To this end, 0.2 to 0.3  106
32D.cl8.6 cells in 0.5 mL RPMI  10% FCS  IL-3 were mixed with 1.5
mL viral supernatant supplemented with IL-3 and seeded onto retronectin/
bovine serum albumin (BSA)–coated 3.5-cm dishes. In all transduction
experiments, a batch of 32D.cl8.6 cells was transduced with pBabe-EGFP
or wt G-CSF-R/EGFP as a reference to be able to estimate the percentage of
transduced cells by fluorescence-activated cell sorter (FACS) analysis. To
obtain individual clones, cells were seeded at approximately 0.3 transduced
cell per well in a 96-well plate with puromycin at a concentration of 1
g/mL. Expression levels of (untagged or EGFP-tagged) G-CSF-R were
assessed by flow cytometry using a FACScan (Becton Dickinson, San
Jose, CA).
COS, 3T3, HeLa, and HEK293 cells were cultured in Dulbecco
modified Eagle medium (DMEM) (high glucose: 4.5 g/L) supplemented
with 10% FCS and 100 IU/mL penicillin, 100 g/mL streptomycin in a
humidified atmosphere at 37°C and 7% CO2. COS, HeLa, and HEK293
cells were plated on glass coverslips and transiently transfected with
G-CSF-R/EGFP fusion constructs using the calcium-phosphate precipita-
tion method. Stable 3T3 cells expressing EGFP-tagged G-CSF-R constructs
were generated by viral transduction as described above for 32D cells. At 2
days after transduction, puromycin was added at a concentration of 1
g/mL for 2 weeks to select for puromycin-resistant cells. To block
clathrin-dependent endocytosis, cells were incubated in culture medium
supplemented with 0.45 M sucrose or 5 mM methyl--cyclodextrin
(Sigma-Aldrich, St Louis, MO) for 3 hours at 37°C.
Preparation of nuclear extracts and electrophoretic mobility
shift assay (EMSA)
Cells were washed 5 times in Hanks balanced salt solution (HBSS) and
deprived of serum and factors for 4 hours at 37°C in RPMI at a density of
1  106 cells/mL. Subsequently, cells were stimulated with G-CSF (100
ng/mL) for 0, 15, 30, or 60 minutes at 37°C. At the different time points, 10
Figure 1. Schematic representation of the intracellular domain of wild-type and
mutant G-CSF receptors. Open boxes represent deleted regions in these mutants.
Single amino acid changes of W650, S749, L753, and L754 are indicated. The
vertical dotted lines depict the 2 internalization motifs (I and II) identified in this study.
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volumes of ice-cold phosphate-buffered saline (PBS) supplemented with 10
M Na3VO4 were added to the cells and nuclear extracts were prepared as
described.27 Subsequently, the nuclear extracts were assayed by EMSA,
using the oligonucleotide probes m67 (5-CATTTCCCGTAAATC), which
binds STAT1 and STAT3, and -cas (5-AGATTTCTAGGAATTCAATCC),
which binds STAT5 and STAT1, as previously described.27
Flow cytometric analysis
To determine G-CSF-R expression levels in 32D.cl8.6 transfectants, cells
(0.5  106) were incubated at 4°C for one hour with 2.5 g/mL biotinylated
mouse antihuman G-CSF-R monoclonal antibody LMM741 and subse-
quently with 12 g/mL phycoerythrin-conjugated streptavidin (SA-PE) in
PSA (PBS supplemented with 1% FCS and 0.02% NaN3 to block
endocytosis) with sequential washings after each step. For internalization
experiments, 3T3 or 32D cells (0.5  106 per time point) were incubated
with biotinylated anti–G-CSF-R antibodies (2.5 g/mL) in the presence or
absence of 100 ng/mL G-CSF or with biotinylated G-CSF (0.2 g/mL) for
one hour at 4°C and subsequently for 0, 15, 30, or 60 minutes at 37°C. Next,
cells were washed in PSA and incubated for one hour at 4°C with SA-PE.
After a final wash in PSA, cells were analyzed by flow cytometry.
Individual internalization profiles of 32D cells expressing wt or mutant
G-CSF-R were quantified by determining the peak channel values of
fluorescence. Mean values and standard errors of means (SEMs) of the
percentage of internalized receptors of at least 3 different clones per
G-CSF-R construct were calculated after 60 minutes at 37°C. Statistical
analysis was performed using a Student t test.
Immunocytochemistry and confocal microscopy
Living cells were examined at 37°C and 5% CO2 in a microchamber
mounted on the microscopic stage of a Zeiss confocal laser scanning
microscope (LSM510). Alternatively, cells were fixed with 4% paraformal-
dehyde and 0.05% glutaraldehyde in 0.1 M phosphate buffer (PB;
pH  7.4) at 4°C for 20 minutes. Fixed cells were washed 3 times with 0.1
M phosphate buffer and incubated in a blocking buffer (PBG) containing
0.5% BSA, 0.2% gelatin, and 2% normal goat serum in PB for 30 minutes at
room temperature. Cells were incubated with primary antibodies for 16
hours at 4°C in PBG containing 0.05% Triton (PBG-T), washed in PBG-T
(3  10 minutes), and incubated with tetramethylrhodamine isothiocyanate
(TRITC) or cyanin 5 (Cy5)–conjugated secondary antibodies (60 minutes,
37°C). After washing with PBG-T, PB, and MilliQ, cells were embedded in
Vectashield (Vector Laboratories, Burlingame, CA) and observed with
CLSM using the multitrack scanning mode to prevent crosstalk in the
detection channels.
To visualize receptor internalization in situ, cells were washed in
PBS/1% FCS, and incubated with biotinylated anti–G-CSF-R antibodies
(2.5 g/mL) with or without G-CSF (100 ng/mL) for one hour at 4°C,
followed by another incubation at 37°C for one hour. After a wash in PSA,
cells were spun onto glass slides and immediately fixed (4% paraformalde-
hyde and 0.05% glutaraldehyde). Fixed cells were washed in PB and
incubated for one hour at 37°C with TRITC-conjugated goat antimouse
secondary antibodies in PBG-T. After washing in PBG-T, PB, and MilliQ,
cells were embedded in Vectashield and observed by CLSM. 3T3 cells were
grown on glass coverslips and incubated with anti–G-CSF-R antibodies
(with or without 100 ng/mL G-CSF) for one hour at 4°C. Subsequently,
cells were incubated for another one hour at 37°C, fixed, and processed as
described for 32D cells.
Results
Signaling properties of G-CSF-R/EGFP fusion proteins
To study the distribution and trafficking of the G-CSF-R in living
cells, we fused the G-CSF-R coding sequence to EGFP cDNA.
Fusion of the EGFP moiety immediately downstream of the signal
peptide resulted in a complete retention of the G-CSF-R/EGFP
fusion protein in the endoplasmic reticulum (ER) (results not
shown), and so these constructs were unsuitable for further study.
When EGFP was attached to the C-terminus, the G-CSF-R/EGFP
fusion protein was expressed on the plasma membrane. To check
whether the EGFP moiety interfered with normal receptor function,
we compared G-CSF responses of wt G-CSF-R/EGFP clones with
wt G-CSF-R clones. Although some clonal variability was ob-
served, 32D.cl8.6 clones expressing either wt G-CSF-R or wt
G-CSF-R/EGFP transiently proliferated in response to G-CSF for 6
to 7 days (Figure 2A), whereupon cells developed into terminally
differentiated neutrophils (Figure 2B).
Cells expressing [d715]G-CSF-R, either with or without EGFP
fusion, displayed sustained exponential growth without any signs
of neutrophilic differentiation (results not shown), as previously
described.23 Moreover, activation of STAT3 and STAT5, implicated
in the control of G-CSF–mediated differentiation and proliferation/
survival, respectively,34,35 was not affected by the presence of the
EGFP moiety at the C-terminus of the G-CSF-R (Figure 2C). These
results indicate that C-terminal fusion of EGFP to the G-CSF-R
does not alter its signaling function and is therefore a reliable tool
to study the dynamics of the G-CSF-R in living cells.
Steady-state distribution of G-CSF-R/EGFP
Using confocal laser scanning microscopy, both wt (Figure 3A) and
[d715]G-CSF-R/EGFP (Figure 3B) were detected predominantly
in intracellular structures of living 32D cells. Because a detailed
assessment of receptor distribution in these cells was not possible
due to low expression levels, small cell size, a low cytoplasm to
nucleus ratio, and poor adherence to glass slides, G-CSF-R/EGFP
fusion proteins were also expressed in COS, 3T3, HEK293, and
HeLa cells. Again, wt G-CSF-R/EGFP was predominantly associ-
ated with cytoplasmic structures in living COS and 3T3 cells
Figure 2. Characterization of the G-CSF responsiveness of myeloid 32D cells
expressing wt or EGFP-fused wt G-CSF-R. (A) Cell proliferation of individual
32D.cl8.6 clones expressing wt G-CSF-R (closed symbols) or wt G-CSF-R/EGFP
(open symbols). Graphs are from independent clones. (B) Maturation of 32D.cl8.6
clones of panel A expressed as the percentage of neutrophils within the living cell
population. (C) EMSA showing kinetics of STAT3 and STAT5 activation in 32D clones
expressing wt G-CSF-R or wt G-CSF-R/EGFP. Cells were serum starved for 4 hours,
stimulated with G-CSF for 0, 15, 30, or 60 minutes, and assayed by EMSA using m67
(STAT3) and -cas (STAT5) probes. The upper band in the STAT3 EMSA represents
STAT3/STAT3, the middle band STAT1/STAT3, and the lowest (weak) band STAT1/
STAT1 complexes. Data are representative of 3 independent experiments with
different cell clones.
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(Figure 3C,E), with only low levels detectable at the plasma
membrane. Similar results were obtained with HEK293 and HeLa
cells (results not shown). In contrast, the truncated receptor fusion
protein ([d715]G-CSF-R/EGFP) consistently appeared at increased
levels at the plasma membrane (Figure 3D,F).
To establish the identity of the EGFP-positive cytoplasmic
structures, we performed a series of double-labeling experiments in
fixed cells using specific organelle markers. Importantly, the
distribution of EGFP-tagged G-CSF-R in fixed cells was similar to
that in living cells. Substantial colocalization was observed be-
tween wt G-CSF-R/EGFP and the Golgi marker GM130,36 in a
region juxtaposing the nucleus (Figure 4A-C). However, consider-
able expression of the G-CSF-R/EGFP fusion protein was detected
in vesicular structures that were distinct from the Golgi apparatus
(Figure 4A). Although a minor overlap could be detected with
markers for the endoplasmic reticulum (BiP37), endoplasmic reticu-
lum intermediate compartment (ERGIC38), and transitional ER
(Sec3139), most of the EGFP-positive cytoplasmic vesicles were
negative for these markers (results not shown), indicating that they
are not in the secretory pathway.
To establish whether these vesicles represented endosomal
structures, antibodies were used directed against specific protein
markers for early endosomes (EEA-1), late endosomes (Rab7), and
late endosomes/lysosomes (Lamp-1). Some colocalization was
observed with EEA-1 and Rab7 (results not shown). However,
based on their costaining with Lamp-1 the majority of EGFP-
positive vesicles appeared to represent late endosomes and lyso-
somes (Figure 4D-F). In contrast, most intracellular [d715]G-CSF-
R/EGFP appeared associated with the Golgi apparatus and only
occasionally colocalized with markers for endosomal structures
(data not shown). To establish whether the aberrant increase in
membrane localization was a consequence of decreased spontane-
ous receptor internalization, cells expressing wt G-CSF-R/EGFP
were incubated for 3 hours in hypertonic sucrose (0.45 M) to block
clathrin-dependent endocytosis.40 As is shown in Figure 5, this
caused an increase in the amount of G-CSF-R/EGFP located at the
plasma membrane. This increase was even more pronounced when
cells were incubated in methyl--cyclodextrin, which extracts
cholesterol from the plasma membrane41 and has been shown to
impair clathrin-mediated endocytosis.42,43 Together, these data
indicate that the aberrant distribution of [d715]G-CSF-R/EGFP in
3T3 cells results from defective spontaneous receptor internalization.
Sequence determinants for steady-state distribution
of G-CSF-R/EGFP
To identify amino acid sequences in the C-terminus of the
G-CSF-R that determine its steady-state distribution, a panel of
G-CSF-R mutants was fused to EGFP and stably expressed in 3T3
cells. First, we compared the distribution of various C-terminal
truncation mutants (Figure 6A). Whereas deletion of 13 ([d800]G-
CSF-R/EGFP; Figure 6A, panel 2) or 34 ([d779]G-CSF-R/EGFP;
Figure 6A, panel 3) amino acids from the C-terminus of the
G-CSF-R did not alter the distribution when compared with wt
G-CSF-R/EGFP (Figure 6A, panel 1), truncation of the C-terminus
at amino acid residue 755, 735, and 715 resulted in accumulated
levels of G-CSF-R/EGFP at the plasma membrane (Figure 6A,
panels 4, 5, and 6, respectively). To more precisely define the
regions in the G-CSF-R that contribute to the steady-state distribu-
tion of the G-CSF receptor, we constructed a series of EGFP-fused
deletion mutants. Whereas removal of amino acids 715 to 735 did
not affect G-CSF-R distribution, deletion of amino acids 735 to 755
caused a significant increase in plasma membrane–associated
G-CSF-R/EGFP (Figure 6B, panels 1-2). Deletion of amino acids
749 to 755 (STQPLL) within this sequence stretch, identical to an
internalization motif identified in gp130,44 caused a similar in-
crease in cell-surface association (Figure 6B, panel 3), whereas
removal of amino acids 735 to 748 yielded a similar distribution as
Figure 3. Distribution of wt and [d715]G-CSF-R/EGFP fusion proteins in
different cell types. 32D (A-B), COS (C-D), and 3T3 (E-F) cells were transfected
with wt (A,C,E) or truncated (B,D,F) EGFP-fusion constructs, and living cells were
observed with CLSM in a microchamber at 37°C and 5% CO2. Confocal micrographs
shown are representative of the distribution of wt or [d715]G-CSF-R/GFP in the
different cell lines. Scale bars are 10 m.
Figure 4. Identification of wt G-CSF-R/EGFP-associated structures in 3T3 cells.
Stably transfected 3T3 cells were plated on glass slides, fixed, and immunolabeled
with a marker of the Golgi apparatus (GM130 [A-C]) or late endosomal/lysosomes
(Lamp-1 [D-F]). Colocalization is shown by merging green (wt G-CSF-R/EGFP; left
panels) with red (GM130 or Lamp-1; middle panels) fluorescence, resulting in a
yellow color in case of colocalization (right panels). Arrows in panels D-F show
examples of G-CSF-R/EGFP-associated vesicles colocalizing with Lamp-1. Confocal
micrographs shown are representative of the distribution of wt G-CSF-R/EGFP. Scale
bars are 10 m.
Figure 5. Increased cell-surface expression of G-CSF-R/EGFP on cells in
hypertonic sucrose or methyl--cyclodextrin. Stably transfected 3T3 cells were
plated on glass coverslips and either left untreated (left panel) or incubated in 0.45 M
sucrose (middle panel) or 5 mM methyl--cyclodextrin (mCD, right panel) for 3
hours before fixation and examination by confocal microscopy. Confocal micrographs
are representative of the distribution of wt G-CSF-R/EGFP in the entire cell
population. Scale bars are 10 m.
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the wt receptor (Figure 6B, panel 4). Importantly, fusion of the
STQPLL internalization motif to [d715]G-CSF-R did not suffice to
restore distribution of [d715]G-CSF-R to that of the wt receptor
(Figure 6B, panel 5), implying the necessity for additional se-
quence information. Indeed, deletion of the immediate downstream
region (amino acids 756 to 769) caused a significant increase in
cell-surface expression as well (Figure 6B, panel 6). Finally,
deletion of amino acids 770 to 779 did not affect distribution of
G-CSF-R/EGFP (results not shown). Similar distribution patterns
for the various constructs were seen in transiently transfected COS,
HEK293, or HeLa cells. Together, these results indicate that the
steady-state distribution of the G-CSF receptor depends on the
integrity of 2 sequence motifs, amino acids 749-755 and 756-769.
Internalization of G-CSF-R is accelerated by ligand binding
The extensive association of wt G-CSF-R/EGFP with lysosomes in
resting 3T3 cells (Figure 4D-F) suggested that G-CSF-R internal-
ization might predominantly be ligand independent, as has been
proposed for gp130.30 To analyze this further, we studied internal-
ization of nonactivating anti–G-CSF-R antibodies, directed against
the extracellular domain of the G-CSF-R, in the absence or
presence of G-CSF in 3T3 cells (Figure 7). After one hour of
incubation at 37°C, anti–G-CSF-R antibodies remained predomi-
nantly associated with the plasma membrane of 3T3 cells stably
expressing wt G-CSF-R/EGFP. A minor fraction of the antibodies
did internalize, however, reflecting spontaneous G-CSF-R internal-
ization (Figure 7A, left panel). When G-CSF was included during
the incubation period, antibody internalization increased dramati-
cally (Figure 7A, right panel). In 3T3 cells expressing [d715]G-CSF-
R/EGFP, no constitutive internalization could be seen after one
hour at 37°C (Figure 7B, left panel). Only a marginal increase in
antibody internalization was seen when G-CSF was included during the
incubation (Figure 7B, right panel). These findings were confirmed by
flow cytometry (Figure 7C-D). Whereas only a minor fraction of
anti–G-CSF-R antibodies had internalized in 3T3 cells expressing wt
G-CSF-R following a one-hour incubation at 37°C (Figure 7C, left
panel), simultaneous inclusion of G-CSF resulted in the uptake of about
75% of the biotinylated antibodies within one hour (Figure 7C, right
panel). Again, 3T3 cells expressing [d715]G-CSF-R/EGFP displayed
little constitutive antibody internalization, which was only slightly
increased when G-CSF was present during the incubation (Figure 7D,
compare left with right panel).
To examine the internalization characteristics of the G-CSF-R
in the appropriate cellular context, we also analyzed receptor
Figure 6. Distribution of wt and mutant EGFP-fused G-CSF-R in 3T3 cells. 3T3 cells were stably transfected with (A) wt or truncated EGFP-fused G-CSF-R constructs or
(B) EGFP-fusion constructs with internal deletions, fixed, and observed using CLSM. Confocal micrographs are representative of the distribution of the various EGFP-fused
G-CSF-R constructs in the entire population. Scale bars are 10 m.
Figure 7. CLSM and flow cytometric analysis of anti–G-CSF-R antibody internalization in 3T3 cells expressing wt or [d715]G-CSF-R/EGFP in the absence or
presence of G-CSF. (A-B) Cells expressing wt (A) or [d715]G-CSF-R/EGFP (B) were incubated with anti–G-CSF-R antibodies for one hour at 37°C, in the absence (left panels)
or presence (right panels) of G-CSF (100 ng/mL), fixed, permeabilized, and incubated with TRITC-conjugated goat antimouse antibodies before examination by CLSM. Scale
bar is 10 m. (C-D) Flow cytometric analysis of internalized biotinylated anti–G-CSF-R antibodies in 3T3 cells expressing wt (C) or [d715]G-CSF-R/EGFP (D) in the absence
(left panels) or presence (right panels) of G-CSF (100 ng/mL). 3T3 cells were allowed to bind biotinylated anti–G-CSF-R antibodies for one hour at 4°C and were subsequently
incubated at 37°C for various times before staining with SA-PE to determine surface-bound G-CSF-R. Bold line indicates 0 minutes; dotted line, 15 minutes; thin line, 30
minutes; dashed line, 60 minutes; and shaded histogram, 0 minutes, in the absence of anti–G-CSF-R antibodies.
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internalization in myeloid 32D cells. Similar to 3T3 cells, a minor
constitutive internalization of anti–G-CSF-R antibodies was ob-
served in 32D cells expressing wt G-CSF-R within the time frame
of one hour, both by CLSM (Figure 8A, left panel) and by flow
cytometry (Figure 8C, left graph). When G-CSF (100 ng/mL) was
included in the incubation, the majority of biotinylated anti–G-
CSF-R antibodies had internalized after one hour at 37°C (Figure
8A, right panel; Figure 8C, right graph). No significant constitutive
internalization was observed in cells expressing [d715]G-CSF-R
(Figure 8B, D, left panels), and this was only marginally increased
in the presence of G-CSF (Figure 8B, D, right panels). In summary,
these experiments establish a crucial role for ligand-binding in the
internalization kinetics of the G-CSF-R.
Receptor activation induces fast, ligand-mediated
G-CSF-R internalization
We next set out to identify which sequence elements within the
C-terminus of the G-CSF-R are important for fast, ligand-mediated
receptor internalization, specifically in myeloid cells. Therefore, a
panel of mutant G-CSF-R constructs (Figure 1) was introduced into
32D.cl8.6 cells. Internalization profiles of at least 3 individual
clones were assessed by flow cytometry (Figure 9A shows a
representative example for each construct) and quantified as
described in “Materials and methods” (Figure 9B). Comparison of
the internalization profiles of the various truncated receptors
revealed that internalization of [d769]G-CSF-R was comparable
with wt G-CSF-R and [d755]G-CSF-R internalization was some-
what delayed, whereas internalization of [d735]G-CSF-R and
[d715]G-CSF-R was completely defective. Subsequent analysis of
deletion constructs revealed that receptor internalization in 32D
cells did not depend on the presence of amino acids 715 to 735 or
amino acids 735 to 748 (Figure 9).
Ligand-induced G-CSF-R internalization did to a large extent
depend on the presence of amino acids 749-755 (Figure 9).
However, fusion of this sequence stretch (internalization domain I
[Figure 1]) to amino acid 715 ([d715-STQPLL]G-CSF-R) did not
restore ligand-induced receptor internalization (Figure 9). Deletion
of the immediately adjacent sequence stretch (amino acids 756 to
769) also caused a significant reduction in receptor internalization
(Figure 9), indicating that the additional presence of this region
(internalization domain II) is a prerequisite for fast, ligand-
mediated G-CSF-R internalization in 32D cells. Indeed, deletion of
both domains ([d749-769]G-CSF-R) inhibited G-CSF-R internal-
ization to the same extent as the truncated [d715]G-CSF-R (Figure
9). Thus, the 2 domains involved in slow constitutive internaliza-
tion (amino acids 749-755 and 756-769; Figure 6) are also crucial
for rapid, ligand-induced receptor internalization. We wondered
whether the role of the ligand was merely to induce a conforma-
tional change (ie, the formation of receptor oligomers) or whether
accelerated internalization depended on receptor activation. To
address this question, we examined the internalization kinetics of
[W650R]G-CSF-R, a mutant that is defective in Jak2 activation
and entirely inert in its signaling properties.18 Whereas this
mutation did not affect the steady-state distribution of G-CSF-R/
EGFP (results not shown), internalization of biotinylated G-CSF was
completely prevented in 32D cells expressing [W650R]G-CSF-R
(Figure 9). This result shows that fast, ligand-mediated G-CSF-R
internalization indeed depends on receptor activation.
Serine 749 is a crucial determinant in the switch from slow
constitutive to fast, ligand-induced G-CSF-R endocytosis
Dileucine-dependent internalization of a number of receptors has
been demonstrated to be induced by activation-mediated phosphor-
ylation of an adjacent serine residue.45-48 As shown previously,27
mutation of the leucines in internalization motif I to alanines
([L753754A]) caused a significant reduction in G-CSF-R internal-
ization (Figure 9). To examine whether phosphorylation of the
immediate upstream serine residue (Ser749) is involved in the
switch from slow constitutive to fast, ligand-mediated G-CSF-R
internalization, we compared internalization of the wt G-CSF-R
with receptors in which this serine was mutated to either an alanine
([S749A]G-CSF-R), to mimic an unphosphorylated residue, or an
aspartic acid ([S749D]G-CSF-R), to mimic a phosphorylated
residue. Whereas [S749A]G-CSF-R displayed a reduction in
ligand-induced receptor internalization, internalization of
[S749D]G-CSF-R was comparable with wt G-CSF-R (Figure 9B).
When the rate of G-CSF–induced internalization was examined in
more detail, the initial internalization of [S749A]G-CSF-R ap-
peared much slower than either wt or [S749D]G-CSF-R (Figure 10).
Figure 8. CLSM and flow cytometric analysis of anti–G-CSF-R antibody internalization in 32D.cl8.6 cells expressing wt or [d715]G-CSF-R in the absence or
presence of G-CSF. (A-B) Cells expressing wt (A) or [d715]G-CSF-R (B) were incubated with anti–G-CSF-R antibodies for one hour at 37°C, in the absence (left panels) or
presence (right panels) of G-CSF (100 ng/mL), spun down on glass slides, fixed, permeabilized, and incubated with TRITC-conjugated goat antimouse antibodies before
examination by CLSM. Original magnification,  600. (C-D) Flow cytometric analysis of internalized biotinylated anti–G-CSF-R antibodies in 32D cells expressing wt (C) or
[d715]G-CSF-R (D) in the absence (left panels) or presence (right panels) of G-CSF (100 ng/mL). 32D cells were allowed to bind biotinylated anti–G-CSF-R antibodies for one
hour at 4°C and were subsequently incubated at 37°C for different time periods before staining with SA-PE to determine surface-bound G-CSF-R. Bold line indicates 0 minutes;
dotted line, 15 minutes; thin line, 30 minutes; dashed line, 60 minutes; and shaded histogram, 0 minutes, in the absence of anti–G-CSF-R antibodies.
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Both cells expressing wt and [S749D]G-CSF-R had internalized approxi-
mately 60% of the surface G-CSF receptors within 5 minutes of
incubation at 37°C, compared with only 20% for cells expressing
[S749A]G-CSF-R. In contrast, spontaneous internalization of anti–G-
CSF-R antibodies was not affected in cells expressing either [S749A]-
or [S749D]G-CSF-R when compared with wt G-CSF-R (Figure 10).
This indicates that the phosphorylation status of this Ser749 is an
important determinant in the rate of ligand-mediated G-CSF-R internal-
ization, but that phosphorylation of this serine residue itself is insuffi-
cient to evoke rapid receptor internalization in the absence of ligand.
Discussion
Receptor endocytosis represents an important mechanism to modu-
late the level, duration, and specificity of growth factor–induced
signal transduction. Perturbations in receptor trafficking have been
associated with a number of pathologic conditions. For example,
EGF receptors with diminished endocytic activity display in-
creased signaling and in some cases enhanced tumorigenesis.49-51
We have previously shown that truncation of G-CSF receptors,
found in patients with severe congenital neutropenia as a result of
acquired nonsense mutations, causes hyperproliferative signal
transduction and defective receptor internalization.23,27,28 Because
of the potential importance of receptor trafficking in the control of
G-CSF–induced signal transduction, we here examined the determi-
nants for G-CSF-R distribution in more detail. We fused the
wild-type or various mutant forms of the G-CSF-R to EGFP, which
allowed us to study receptor distribution in living cells using
CLSM. The association of [d715]G-CSF-R/EGFP with the plasma
membrane of resting cells appeared dramatically increased com-
pared with wt G-CSF-R/EGFP (Figure 3). This accumulation may
have arisen either from aberrant forward transport or from reduced
spontaneous receptor internalization. ER to Golgi transport of
newly synthesized membrane receptors is believed to be facilitated
by diacidic residues (D/E X D/E) that are commonly found in
membrane proteins.52 The G-CSF-R contains 2 such motifs, both of
which are located N-terminal to amino acid 715, notably EED
(656-658) and EEDE (677-680). Both wt G-CSF-R/EGFP and
[d715]G-CSF-R/EGFP were found to be concentrated in the Golgi
apparatus and were both marginally associated with the ER,
ERGIC, and transitional ER (tER) (results not shown). The
substantial colocalization of wt G-CSF-R/EGFP–associated cytoso-
lic vesicles with the late endosomal/lysomal marker protein
Lamp-1 (Figure 4D-F) suggests that the different cell-surface
expression levels between wt and [d715]G-CSF-R results primarily
from a severe reduction in spontaneous internalization of [d715]G-
CSF-R. Moreover, spontaneous receptor internalization, assessed
by uptake of anti–G-CSF-R antibodies, appeared severely reduced
in 3T3 cells expressing [d715]G-CSF-R/EGFP when compared
with wt G-CSF-R/EGFP (Figures 6-7). Finally, blocking clathrin-
coated pit-dependent internalization by hypertonic sucrose or in
methyl--cyclodextrin41-43 caused a substantial increase in the level
of plasma membrane–associated wt G-CSF-R/EGFP (Figure 5).
The observed decrease in spontaneous internalization of anti–G-
CSF-R antibody in 32D cells expressing [d715]G-CSF-R, when
compared with wt (Figure 8A-B, left panels), suggests that a
Figure 9. Internalization of wt and mutant G-CSF receptors in 32D.cl8.6 cells.
(A) 32D cells expressing various mutant G-CSF receptors were allowed to bind
biotinylated G-CSF at 4°C and were subsequently incubated at 37°C for 0, 15, or 60
minutes at 37°C before staining with SA-PE to determine surface-bound biotinylated
G-CSF. Shown are internalization profiles of a representative 32D clone. Bold line
indicates 0 minutes; dotted line, 15 minutes; thin line, 60 minutes; and shaded
histogram, 0 minutes, with initial binding in the presence of excess nonbiotinylated
G-CSF. (B) Quantification of the mean percentage of internalized biotinylated G-CSF
in 32D cells. Shown are mean values and SEMs of the percentage of internalized
receptors, determined by assessing peak channel values of fluorescence of at least 3
different clones per construct after 60 minutes of internalization (*P  .05).
Figure 10. Internalization kinetics of wt, [S749A], and [S749D]G-CSF-R in
32D.cl8.6 cells. 32D cells expressing wt (squares), [S749A] (triangles), or [S749D]G-
CSF-R (circles) were allowed to bind biotinylated anti–G-CSF-R antibodies in the
absence (open symbols) or presence (closed symbols) of G-CSF for one hour at 4°C
and were subsequently incubated at 37°C for 0, 5, 15, or 30 minutes at 37°C before
staining with SA-PE to determine surface-bound G-CSF-R. The percentage of
internalized G-CSF receptors was determined by assessing peak channel values of
fluorescence at the different time points. This is a representative experiment out of 3
independent experiments.
G-CSF RECEPTOR DISTRIBUTION AND INTERNALIZATION 577BLOOD, 15 JANUARY 2004  VOLUME 103, NUMBER 2
similar difference in distribution between wt and [d715]G-CSF-R/
EGFP exists in 32D cells as well. However, we were unable to
assess this by confocal microscopy due to low overall expression
levels, a low cytoplasm-to-nucleus ratio, and a low surface-to-
volume ratio.
Sequence determinants for G-CSF-R/EGFP distribution over-
lapped to a large extent with sequences controlling fast, ligand-
mediated G-CSF-R internalization in 32D cells. Both are predomi-
nantly controlled by 2 COOH-terminal internalization motifs
(internalization motifs I and II [Figure 1]; compare Figure 6 with
Figure 9), which presumably constitute core internalization ele-
ments. By using nonactivating anti–G-CSF-R antibodies we dem-
onstrated that receptor internalization could be greatly accelerated
by addition of G-CSF (Figures 7-8). Mutation of Trp650 to Arg,
previously shown to cause inactivation of the G-CSF-R by
preventing activation of Jak2,18 completely prevented ligand-
induced G-CSF-R internalization (Figure 9), while the steady-state
distribution of [W650R]G-CSF-R/EGFP did not differ from the wt
G-CSF-R/EGFP (results not shown). This indicates that receptor-
mediated activation of JAK kinases is essential for fast G-CSF-R
internalization in 32D cells, while leaving spontaneous receptor
internalization, guided by internalization motifs I and II (Figure 1),
unaffected.
Activated Jak kinases induce phosphorylation of tyrosine
residues in the C-terminus of the G-CSF-R to generate docking
sites for signaling proteins, adapter proteins, and negative regula-
tory proteins.5,12,14,20,53 One of the identified internalization motifs
(amino acids 756-769) contains a potential tyrosine-based YXX	
internalization motif (in which X is any amino acid and 	 has a
bulky hydrophobic side chain). Recently, internalization of the
thrombopoietin receptor Mpl was shown to be controlled by a
dileucine internalization motif together with such a C-terminal
tyrosine motif.54 Internalization guided by the latter motif appeared
dependent of Jak2 activation. However, mutation of all C-terminal
tyrosine residues in the G-CSF-R did not reduce ligand-induced
G-CSF-R internalization,27 arguing against a prominent role for
phosphorylation of this tyrosine in G-CSF-R internalization.
The observation that ligand-induced internalization of
[S749A]G-CSF-R was severely reduced while internalization of
[S749D]G-CSF-R was unaffected when compared with wt G-
CSF-R (Figures 9-10) suggested that G-CSF–induced activation of
a serine kinase is required for efficient ligand-mediated G-CSF-R
internalization. A number of receptors contain dileucine internaliza-
tion motifs that mediate receptor internalization depending on
phosphorylation of a serine residue at position 4 to 5 upstream
of the dileucine pair45-48,55 by facilitating the interaction with
AP-2.48 Preincubation of 32D cells expressing wt G-CSF-R with
various serine/threonine-kinase inhibitors, including staurosporin,
H89, a protein kinase C (PKC) inhibitor (Go¨6976) and inhibitors of
MAPK activity (U0126, PD98059, and SB203580), did not prevent
ligand-mediated G-CSF-R internalization. The identity of the
kinase responsible for phosphorylation of Ser749 thus remains to
be determined. Although phosphorylation of Ser749 may facilitate
recognition of the dileucine internalization motif to induce ligand-
mediated G-CSF-R internalization, substitution of Ser749 for an
Asp was not sufficient to accelerate internalization of anti–G-
CSF-R antibodies in the absence of ligand (Figure 10). Rapid
receptor internalization may therefore also depend on G-CSF–
induced receptor oligomerization and/or activation of additional
internalization pathways.
Agonist stimulation of G-CSF-R/gp130 chimeras in 3T3 cells
identified the serine (Ser782) within the dileucine internalization
motif (STQPLL) as the major phosphorylated serine residue in the
cytoplasmic tail of gp130.56 However, the role of this serine in the
regulation of cell-surface expression of gp130 is somewhat equivo-
cal. Whereas mutation of this serine to an alanine increased
cell-surface expression of G-CSF-R/gp130 chimeric proteins in
resting COS cells,56 it did not affect internalization of IL-6 in COS
cells cotransfected with wt gp130 and IL-6-R.44 Interestingly,
mutation of the further upstream serine residue (Ser780) to Ala
reduced initial internalization of IL-6 by 50%,44 indicating that
ligand-induced phosphorylation of a serine residue upstream of the
dileucine internalization motif may control the rate of internaliza-
tion of gp130 as well.
In conclusion, our study provides 2 major new insights in the
regulation of cell-surface expression of the G-CSF-R. First,
steady-state levels of G-CSF-R associated with the plasma mem-
brane are low due to spontaneous receptor internalization. Absence
of the internalization domains, as observed in truncated G-CSF
receptors of SCN patients, results in an increased number of
cell-surface–associated G-CSF-Rs. Second, we have demonstrated
that G-CSF–induced receptor activation caused a dramatic accelera-
tion of receptor internalization, depending at least partly on the
phosphorylation status of a Ser749, which may involve regulation
of the accessibility of the downstream dileucine internalization
motif. These results are in contrast with findings reported for other
members of the hematopoietin receptor superfamily (gp130, eryth-
ropoietin receptor [Epo-R], and GH-R) that are internalized
independent of receptor activation.30-32 This indicates that the
mechanisms underlying receptor endocytosis vary between differ-
ent hematopoietin receptors. Currently, we are examining G-CSF–
mediated signal transduction from the presented G-CSF receptor
mutants to establish the importance of receptor endocytosis in
G-CSF–induced myeloid proliferation and differentiation.
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